On-Demand Videos

Share

Program Content

Activities

  • EGFR+/High PD-L1 NSCLC
    Treating a Patient With Newly Diagnosed Metastatic EGFR Mutant–Positive NSCLC and High PD-L1 Expression
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 29, 2018

  • PD-L1 for Progressive NSCLC
    PD-L1 Testing in the Setting of Progressive NSCLC After Chemotherapy
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 04, 2018

  • PD-L1–Negative Lung Adenocarcinoma
    Treating a Patient With Newly Diagnosed Metastatic Lung Adenocarcinoma and < 1% PD-L1 Expression
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 07, 2018

  • PD-L1–Low Metastatic Squamous NSCLC
    Treating a Patient With Newly Diagnosed Metastatic Squamous NSCLC and Low PD-L1 Expression
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 21, 2018

Provided by

ProCE Banner

Supporters

AstraZeneca

Bristol Myers Squibb

Celgene TEXT Only

Genentech TEXT Only

Lilly

Merck Oncology

Novartis Pharmaceuticals Corporation

Takeda Oncology